GGO Vergunningendatabase

Zoekcriteria
Zoekresultaat
IM-MV 19-002_004 Universitair Medisch Centrum Utrecht Clinical testing of JNJ-68284528, composed of autologous T cells genetically modified with a lentiviral vector (LVV) to express a chimeric antigen receptor (CAR) that, upon reinfusion into the patient, recognize and kill B-cell maturation antigen (BCMA)-expressing tumour cells 22-03-2021 Vergunning verleend
IM-MV 19-011_004 Erasmus MC Clinical testing of JNJ-68284528, composed of autologous T cells genetically modified with a lentiviral vector (LVV) to express a chimeric antigen receptor (CAR) that, upon reinfusion into the patient, recognize and kill B-cell maturation antigen (BCMA)-expressing tumour cells 22-03-2021 Vergunning verleend
IM-MV 19-012_004 VU medisch centrum Clinical testing of JNJ-68284528, composed of autologous T cells genetically modified with a lentiviral vector (LVV) to express a chimeric antigen receptor (CAR) that, upon reinfusion into the patient, recognize and kill B-cell maturation antigen (BCMA)-expressing tumor cells 31-03-2021 Vergunning verleend
IM-MV 19-014_004 UMCG Clinical testing of JNJ-68284528, composed of autologous T cells genetically modified with a lentiviral vector (LVV) to express a chimeric antigen receptor (CAR) that, upon reinfusion into the patient, recognize and kill B-cell maturation antigen (BCMA)-expressing tumour cells 22-03-2021 Vergunning verleend
IM-MV 20-015_000 AMC A Clinical Study to Evaluate the Safety, Reactogenicity, Immunogenicity and Efficacy of an Ad26 and/or MVA-BN clinical vector for the prevention or treatment of infectious diseases 01-04-2021 Vergunning verleend